Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandramouli Chiruta

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|December 24, 2011
Chemical modification of the multitarget neuroprotective compound fisetinChandramouli Chiruta, David Schubert, Richard Dargusch, et al.
Bioorganic & Medicinal Chemistry|April 16, 2013
Metabolism of a potent neuroprotective hydrazideChandramouli Chiruta, Yanrong Zhao, Fangling Tang, et al.
Alzheimer'S Research & Therapy|May 16, 2013
The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease miceMarguerite Prior, Richard Dargusch, Jennifer L Ehren, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 7, 2016
Selecting for neurogenic potential as an alternative for Alzheimer's disease drug discoveryMarguerite Prior, Joshua Goldberg, Chandramouli Chiruta, et al.
ACS Chemical Neuroscience|June 6, 2014
Back to the future with phenotypic screeningMarguerite Prior, Chandramouli Chiruta, Antonio Currais, et al.
Journal of Ethnopharmacology|June 28, 2014
Screening and identification of neuroprotective compounds relevant to Alzheimer׳s disease from medicinal plants of S. Tomé e PríncipeAntonio Currais, Chandramouli Chiruta, Marie Goujon-Svrzic, et al.
Plos One|December 24, 2011
A novel neurotrophic drug for cognitive enhancement and Alzheimer's diseaseQi Chen, Marguerite Prior, Richard Dargusch, et al.
The Journal of Organic Chemistry|September 11, 2009
Total synthesis of the marine alkaloid halichlorine: development and use of a general route to chiral piperidinesDazhan Liu, Hukum P Acharya, Maolin Yu, et al.
Aging Cell|January 10, 2018
The mitochondrial ATP synthase is a shared drug target for aging and dementiaJoshua Goldberg, Antonio Currais, Marguerite Prior, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|December 24, 2011
Chemical modification of the multitarget neuroprotective compound fisetinChandramouli Chiruta, David Schubert, Richard Dargusch, et al.
Bioorganic & Medicinal Chemistry|April 16, 2013
Metabolism of a potent neuroprotective hydrazideChandramouli Chiruta, Yanrong Zhao, Fangling Tang, et al.
Alzheimer'S Research & Therapy|May 16, 2013
The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease miceMarguerite Prior, Richard Dargusch, Jennifer L Ehren, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 7, 2016
Selecting for neurogenic potential as an alternative for Alzheimer's disease drug discoveryMarguerite Prior, Joshua Goldberg, Chandramouli Chiruta, et al.
ACS Chemical Neuroscience|June 6, 2014
Back to the future with phenotypic screeningMarguerite Prior, Chandramouli Chiruta, Antonio Currais, et al.
Journal of Ethnopharmacology|June 28, 2014
Screening and identification of neuroprotective compounds relevant to Alzheimer׳s disease from medicinal plants of S. Tomé e PríncipeAntonio Currais, Chandramouli Chiruta, Marie Goujon-Svrzic, et al.
Plos One|December 24, 2011
A novel neurotrophic drug for cognitive enhancement and Alzheimer's diseaseQi Chen, Marguerite Prior, Richard Dargusch, et al.
The Journal of Organic Chemistry|September 11, 2009
Total synthesis of the marine alkaloid halichlorine: development and use of a general route to chiral piperidinesDazhan Liu, Hukum P Acharya, Maolin Yu, et al.
Aging Cell|January 10, 2018
The mitochondrial ATP synthase is a shared drug target for aging and dementiaJoshua Goldberg, Antonio Currais, Marguerite Prior, et al.
Pageof 1